4//SEC Filing
LESCHLY JAN 4
Accession 0001209191-09-035121
CIK 0001103021other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:05 PM ET
Size
51.4 KB
Accession
0001209191-09-035121
Insider Transaction Report
Form 4
Ramsay David Russ
10% Owner
Transactions
- Sale
Common Stock
2009-06-30$6.68/sh−32,640$217,918→ 299,074 total(indirect: See Footnote) - Sale
Common Stock
2009-07-01$6.76/sh−50,000$337,760→ 249,074 total(indirect: See Footnote)
KARABELAS ARGERIS N
10% Owner
Transactions
- Sale
Common Stock
2009-06-30$6.68/sh−32,640$217,918→ 299,074 total(indirect: See Footnote) - Sale
Common Stock
2009-07-01$6.76/sh−50,000$337,760→ 249,074 total(indirect: See Footnote)
CDC IV LLC
10% Owner
Transactions
- Sale
Common Stock
2009-07-01$6.76/sh−50,000$337,760→ 249,074 total(indirect: See Footnote) - Sale
Common Stock
2009-06-30$6.68/sh−32,640$217,918→ 299,074 total(indirect: See Footnote)
CDC Operations LLC
10% Owner
Transactions
- Sale
Common Stock
2009-07-01$6.76/sh−50,000$337,760→ 249,074 total(indirect: See Footnote) - Sale
Common Stock
2009-06-30$6.68/sh−32,640$217,918→ 299,074 total(indirect: See Footnote)
LESCHLY JAN
10% Owner
Transactions
- Sale
Common Stock
2009-07-01$6.76/sh−50,000$337,760→ 249,074 total(indirect: See Footnote) - Sale
Common Stock
2009-06-30$6.68/sh−32,640$217,918→ 299,074 total(indirect: See Footnote)
Footnotes (3)
- [F1]On June 30, 2009, CDC IV, LLC sold an aggregate of 32,640 shares of Common Stock of BioDelivery Sciences International, Inc. at an average gross price per share of $6.6764. The individual trades made by CDC IV, LLC on June 30, 2009 are set forth on Exhibit 1(a) attached hereto.
- [F2]The reportable securities are owned directly by CDC IV, LLC and indirectly by CDC Operations LLC, David R. Ramsay, Argeris Karabelas and Jan Leschly. CDC Operations LLC disclaims beneficial ownership of the reportable securities and this report shall not be deemed an admission that CDC Operations LLC is the beneficial owner of such securities for purposes of Section 16 or any other purpose, except to the extent of its pecuniary interest therein. David R. Ramsay, Argeris Karabelas and Jan Leschly are each partners of CDC Operations LLC. Messrs. Ramsay, Karabelas and Leschly each disclaims beneficial ownership of the reportable securities and this report shall not be deemed an admission that Messrs. Ramsay, Karabelas and Leschly is the beneficial owner of such securities for purposes of Section 16 or any other purpose, except to the extent of their pecuniary interest therein.
- [F3]On July 1, 2009, CDC IV, LLC sold an aggregate of 50,000 shares of Common Stock of BioDelivery Sciences International, Inc. at an average gross price per share of $6.7552. The individual trades made by CDC IV, LLC on July 1, 2009 are set forth on Exhibit 1(b) attached hereto.
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
CIK 0001103021
Entity typeother
Related Parties
1- filerCIK 0001204568
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 4:05 PM ET
- Size
- 51.4 KB